In vivo vascular engineering of vein grafts: Directed migration of smooth muscle cells by perivascular release of elastase limits neointimal proliferation

Journal of Vascular and Interventional Radiology

Volumn 13, Issue 7, 2002, Pages 709-715

  Amabile, Philippe G ^a,b   Wong, Humberto ^a   Uy, Marie ^a   Boroumand, Sara ^a   Elkins, Christopher J ^a   Yuksel, Eser ^c   Waugh, Jacob M ^a   Dake, Michael D ^a  

^a STANFORD UNIVERSITY   (United States)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Blood vessels, flow dynamics; Grafts, stenosis or thrombosis; Intimal hyperplasia; Smooth muscle cells

Indexed keywords

ELASTASE; ELASTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BYPASS SURGERY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME DEGRADATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VEIN GRAFT;

EID: 0036074840     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(07)61848-X     Document Type: Article

References (39)

1. Endothelial cell injury in cardiovascular surgery: The intimal hyperplastic response
2. The natural history of intermediate and critical vein graft stenosis: Recommendations for continued surveillance or repair
3. Aortocoronary saphenous vein bypass grafts: Long-term patency, morphology and blood flow in patients with patent grafts early after surgery
4. Aortocoronary saphenous vein bypass grafts
5. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years
6. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention
7. Cell biology of atherosclerosis
8. Migration of smooth muscle and endothelial cells: Critical events in restenosis
9. The molecular bases of restenosis
10. Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits after heterotopic cardiac transplantation
11. Elastase and the pathobiology of unexplained pulmonary hypertension
12. Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor
13. Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells: Alpha 2 beta 1 integrin is required for chemotaxis across type I collagencoated membranes
14. Inhibition of neointimal formation by natural heparan sulfate proteoglycans of the arterial wall
15. The extracellular matrix in balloon arterial injury: A novel target for restenosis prevention
16. Substratum-bound elastin peptide inhibits aortic smooth muscle cell migration in vitro
17. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat
18. In vivo vascular engineering: Directed migration of smooth muscle cells to limit neointima
19. Perivascular release of insulin-like growth factor-1 limits neointima formation in the balloon-injured artery by redirecting smooth muscle cell migration
20. De novo adipose tissue generation through long-term, local delivery of insulin and insulin-like growth factor-1 by PLGA/PEG microspheres in an in vivo rat model: A novel concept and capability
21. Vascular endothelial growth factor enhances atherosclerotic plaque progression
22. Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model
23. Gene therapy to promote thromboresistance: Local overexpression of tissue plasminogen activator to prevent arterial thrombosis in an in vivo rabbit model
24. Thrombomodulin overexpression to limit neointima formation
25. Gene therapy for vascular diseases
26. Arterial remodeling in atherosclerosis and restenosis: A vague concept of a distinct phenomenon
27. Remodeling of the coronary artery after vascular injury
28. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo
29. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease
30. Elastin is an essential determinant of arterial morphogenesis
31. Elastin-elastase-atherosclerosis revisited
32. Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase
33. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis
34. Vascular smooth muscle cell detachment from elastin and migration through elastic laminae is promoted by chondroitin sulfate-induced "shedding" of the 67-kDa cell surface elastin binding protein
35. Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate
36. Functional interplay between interleukin-1 receptor and elastin binding protein regulates fibronectin production in coronary artery smooth muscle cells
37. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes
38. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor